¹ Clinical testing via visual assessment using Griffith’s 10-point scale analysis on 36 participants immediately after the first application.
² Clinical testing via visual assessment using Griffith’s 10-point scale analysis on 34 participants after twice a day use for 28 days.
³ Clinical testing via instrumental analysis with 36 participants immediately after the first application.
⁴ Clinical testing via instrumental analysis with 34 participants after twice a day use for 28 days.
⁵ Result based on clinical self-assessment with 36 participants immediately after the first application.
⁶ Result based on clinical self-assessment with 34 participants after twice a day use for 28 days.
⁷ Result based on an apparent age evaluation performed by an expert, using the mean value of 34 participants after twice a day use for 28 days.
⁸ Clinical testing via bioinstrumental analysis with 33 participants after twice a day use for 2 weeks.
⁹ Based on an independent clinical study with 32 participants after twice a day use for 2 weeks.
¹⁰ Clinical testing via bioinstrumental analysis with 33 participants after twice a day use for 4 weeks. 
¹¹ Based on an independent clinical study with 32 participants after twice a day use for 4 weeks.